A Multi-Center Phase 2/3 Randomized Double-Blind Placebo-Controlled Parallel- Group Safety and Efficacy Study of Dapansutrile Tablets in Subjects with an Acute Gout Flare

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
  • Age: Between 18 Year(s) - 89 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Clinical diagnosis of gout.
    2. Confirmation of a gout flare in the target joint.
    3. Acceptable overall medical condition to safely participate in the study and complete all study procedures.
    4. Able and willing to

You may not be eligible for this study if the following are true:

    1. Woman of childbearing potential, or man whose sexual partner(s) is a woman of childbearing potential, who:
      • Is or intends to become pregnant (including use of fertility drugs) while participating in the study;
      • Is lacta

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.